S E Shackney|P A Bunn|S S Ford - JoVE Visualize

Showing results (171-180 of 261) with videos related to

Pageof 27

Sort By:

Biological Chemistry|March 22, 2001

Metabolism-resistant bradykinin antagonists: development and applicationsJ M Stewart, L Gera, E J York, et al.

Cancer Treatment Reports|March 1, 1981

Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancerM H Cohen, R Makuch, A Johnston-Early, et al.

Cytometry|January 11, 1992

Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteinsA A Pollice, J P McCoy, S E Shackney, et al.

Cytometry|September 1, 1995

Assessing sequential oncogene amplification in human breast cancerL E Janocko, J F Lucke, D W Groft, et al.

Seminars in Oncology|August 1, 1997

Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology TeamK M Pisters, M G Kris, P A Bunn, et al.

Cancer Treatment Reports|April 1, 1979

Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopyG P Schechter, P A Bunn, A B Fischmann, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1987

Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibodyA M Keenan, J N Weinstein, J L Mulshine, et al.

The American Review of Respiratory Disease|May 1, 1981

Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapyD C Ihde, R W Makuch, D N Carney, et al.

Lancet (London, England)|March 13, 1982

Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancerD N Carney, P J Marangos, D C Ihde, et al.

Cancer Treatment Reports|May 1, 1982

Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lungD C Ihde, A Johnston-Early, D N Carney, et al.

Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:

Pageof 27

Biological Chemistry|March 22, 2001

Metabolism-resistant bradykinin antagonists: development and applicationsJ M Stewart, L Gera, E J York, et al.

Cancer Treatment Reports|March 1, 1981

Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancerM H Cohen, R Makuch, A Johnston-Early, et al.

Cytometry|January 11, 1992

Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteinsA A Pollice, J P McCoy, S E Shackney, et al.

Cytometry|September 1, 1995

Assessing sequential oncogene amplification in human breast cancerL E Janocko, J F Lucke, D W Groft, et al.

Seminars in Oncology|August 1, 1997

Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology TeamK M Pisters, M G Kris, P A Bunn, et al.

Cancer Treatment Reports|April 1, 1979

Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopyG P Schechter, P A Bunn, A B Fischmann, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1987

Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of indium-111-labeled T101 monoclonal antibodyA M Keenan, J N Weinstein, J L Mulshine, et al.

The American Review of Respiratory Disease|May 1, 1981

Prognostic implications of stage of disease and sites of metastases in patients with small cell carcinoma of the lung treated with intensive combination chemotherapyD C Ihde, R W Makuch, D N Carney, et al.

Lancet (London, England)|March 13, 1982

Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancerD N Carney, P J Marangos, D C Ihde, et al.

Cancer Treatment Reports|May 1, 1982

Lack of efficacy of high-dose methotrexate by 30-hour infusion in patients with progressive small cell carcinoma of the lungD C Ihde, A Johnston-Early, D N Carney, et al.

Pageof 27